Exosomes and microvesicles from resistant HNSCC cells are enriched with ERCC1 and XRCC1, which facilitate nucleotide and base excision repair, thereby neutralizing the cytotoxic effects of DNA-damaging agents (15, 17, 30, 31). The gene discussed is XRCC1; the disease is head and neck squamous cell carcinoma.